Our mission is to orchestrate a cure for muscular dystrophies caused by dysferlin protein deficiency. These are collectively termed dysferlinopathy, and clinically are referred to as LGMD2B, LGMDR2, or Miyoshi Myopathy 1 (MM1). Our non-traditional funding model strategically funds and partners with scientific researchers, institutions, and companies. Additionally, we provide logistical support in drug development and clinical trials and have built a strong patient support and advocacy platform.
Company Details
- Employees
- 13
- Founded
- 2005
- Address
- 9706 4th Ave Ne,
- Industry
- Research
- Website
- jain-foundation.org
- Keywords
- patient advocacy, Fund scientific projects focused on Dysferlinopathy, Dysferlin specific patient registry.
- HQ
- Seattle, WA
Jain Foundation Inc Questions
Jain Foundation Inc's website is jain-foundation.org
Jain Foundation Inc's LinkedIn profile is https://www.linkedin.com/company/jain-foundation-inc
Jain Foundation Inc has
13 employees.
View email and phone details for 13
employees at Jain Foundation Inc.
Jain Foundation Inc's industry is
Research
Jain Foundation Inc's top competitors are
Project 8p Foundation,
Meet Life Sciences,
Jain Family Institute,
The Ryr-1 Foundation,
Sarepta Therapeutics,
The Jain Foundation,
Atamyo Therapeutics,
Alzheimer's Drug Discovery Foundation,
Lgmd Awareness Foundation, Inc.,
Taysha Gene Therapies.
Jain Foundation Inc's categories are Research
Jain Foundation Inc's founding year is 2005
